2021 Psychedelic Investor Guide Released
Ryan Allway October 20th, 2021 Psychedelics, Top News MIAMI, Oct. 20, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today its wholly owned KetaDASH will be one of the sponsors of the 2021... Read more
Silo Wellness’ Marley One Line of Functional Mushrooms Now Sold On Amazon
Ryan Allway October 12th, 2021 Psychedelics TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“Silo Wellness” or the “Company”) (CSE: SILO) (OTCQB: SILFF) (FRA: 3K70), a leading global psychedelics company, today announced the listing of its portfolio of Marley One branded mushroom products on multinational e-commerce conglomerate... Read more
Ryan Allway October 12th, 2021 Psychedelics, Top News MIAMI, Oct. 12, 2021 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has hired KGK Science Inc., a contract research organization (CRO) that is... Read more
atai Life Sciences announces the launch of PsyProtix, to develop a precision psychiatry approach for Treatment-Resistant Depression (TRD)
NEW YORK, Oct. 11, 2021 (GLOBE NEWSWIRE) — atai Life Sciences (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, announced the launch of PsyProtix, a new platform company formed with Chymia LLC, a Duke University biotechnology spinout. PsyProtix is a precision... Read more
Revitalist Signs LOI to Acquire Virginia Ketamine Clinic
Ryan Allway October 7th, 2021 Psychedelics VANCOUVER, British Columbia, October 07, 2021–(BUSINESS WIRE)–REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company“) (CSE: CALM) (CSNX: CALM.CN) (OTC: RVLWF) is pleased to announce that it entered into a non-binding letter of intent (“LOI“) dated October 5, 2021 to acquire a ketamine clinic... Read more
Psyched Wellness Announces Commencement of Next Pre-Clinical Study on AME-1
Ryan Allway October 7th, 2021 Psychedelics Toronto, Ontario–(Newsfile Corp. – October 7, 2021) – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that KGK Science, a licensed... Read more
HAVN Life Files Final Base Shelf Prospectus October 7, 2021 News
Ryan Allway October 7th, 2021 Psychedelics VANCOUVER, BC, Oct. 7, 2021 /CNW/ – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) is pleased to announce that it has filed its final short form base shelf prospectus (the “Final Shelf Prospectus“) with the securities commissions... Read more
MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary – MYND Diagnostics Ltd.
Ryan Allway October 7th, 2021 Psychedelics MYND Diagnostics was formed to commercialize proprietary biomarker diagnostic tests for patients suffering from MDD, TRD and other psychiatric disorders. VANCOUVER, BC, Oct. 7, 2021 /CNW/ – MYND Life Sciences Inc. (CSE: MYND) (OTC: MYNDF) (“MYND” or the “Company“) is pleased to announce the formation of its... Read more
Blackhawk Growth’s MindBio Therapeutics Brings Digital Mental Health Technology To Psychedelics Clinical Trials
Ryan Allway October 7th, 2021 Psychedelics Vancouver, British Columbia – TheNewswire – October 7, 2021 – Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (Frankfurt:0JJ) (the “Company” or “Blackhawk”) is pleased to announce that MindBio Therapeutics is developing a mental health technology platform to integrate with psychedelic treatments in clinical trials in... Read more
Clearmind Medicine Partners With Clinipace to Commence Processes Towards FDA Approval
Ryan Allway October 7th, 2021 Psychedelics The Regulatory affairs and CRO will oversee the Company’s efforts to secure an IND review of MEAI as a potential treatment for Alcohol Use Disorder and binge drinking Toronto, Ontario, Oct. 07, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0),... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )